Augurex Life Sciences Corp.

$27,000.00 CAD

≈ 4 months of average Canadian pay
Department
National Research Council Canada
Program
CanExport
Recipient country
Canada
Fiscal year
2019-2020
Agreement period
May 9, 2019 – February 28, 2020
Reference
nrc-cnrc:172-2019-2020-Q1-928230

Published purpose

The 14-3-3 eta JOINTstat® test can be used as an aid in the diagnosis of patients with Rheumatoid Arthritis. Augurex plans to commercialize 14-3-3 eta tests and reagents in Germany & Australia to expand our commercial reach.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions